Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (51-60 of 411) with videos related to

Pageof 42
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2008
Novel MRI techniques in the assessment of dementiaStefan J Teipel, Thomas Meindl, Lea Grinberg, et al.
Journal of Geriatric Psychiatry and Neurology|August 2, 2006
Biomarkers in the diagnosis of Alzheimer's disease: are we ready?Trey Sunderland, Harald Hampel, Masatoshi Takeda, et al.
Progress in Neurobiology|June 14, 2011
Discovery and development of integrative biological markers for schizophreniaViola Oertel-Knöchel, Robert A Bittner, Christian Knöchel, et al.
Psychiatry Research|September 6, 2011
Impact of employment status and work-related factors on risk of completed suicide. A case-control psychological autopsy studyBarbara Schneider, Kristin Grebner, Axel Schnabel, et al.
Plos One|January 6, 2018
Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic miceSoizic Lecocq, Katia Spinella, Bruno Dubois, et al.
Trends in Neurosciences|July 8, 2017
Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's DiseasePatrizia A Chiesa, Enrica Cavedo, Simone Lista, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-AnalysisShinji Matsunaga, Taro Kishi, Peter Annas, et al.
Trends in Neurosciences|June 24, 2011
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementiaMichael Ewers, Reisa A Sperling, William E Klunk, et al.
Expert Review of Proteomics|June 15, 2019
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in developmentFilippo Baldacci, Simone Lista, Giovanni Palermo, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 30, 2012
Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controlsMarkus J Schwarz, Gilles J Guillemin, Stefan J Teipel, et al.
Pageof 42

Showing results (51-60 of 411) with videos related to

Sort By:
Pageof 42
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2008
Novel MRI techniques in the assessment of dementiaStefan J Teipel, Thomas Meindl, Lea Grinberg, et al.
Journal of Geriatric Psychiatry and Neurology|August 2, 2006
Biomarkers in the diagnosis of Alzheimer's disease: are we ready?Trey Sunderland, Harald Hampel, Masatoshi Takeda, et al.
Progress in Neurobiology|June 14, 2011
Discovery and development of integrative biological markers for schizophreniaViola Oertel-Knöchel, Robert A Bittner, Christian Knöchel, et al.
Psychiatry Research|September 6, 2011
Impact of employment status and work-related factors on risk of completed suicide. A case-control psychological autopsy studyBarbara Schneider, Kristin Grebner, Axel Schnabel, et al.
Plos One|January 6, 2018
Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic miceSoizic Lecocq, Katia Spinella, Bruno Dubois, et al.
Trends in Neurosciences|July 8, 2017
Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's DiseasePatrizia A Chiesa, Enrica Cavedo, Simone Lista, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-AnalysisShinji Matsunaga, Taro Kishi, Peter Annas, et al.
Trends in Neurosciences|June 24, 2011
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementiaMichael Ewers, Reisa A Sperling, William E Klunk, et al.
Expert Review of Proteomics|June 15, 2019
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in developmentFilippo Baldacci, Simone Lista, Giovanni Palermo, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 30, 2012
Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controlsMarkus J Schwarz, Gilles J Guillemin, Stefan J Teipel, et al.
Pageof 42